V I S I T
WORLD’S CLINICAL LABORATORY NEWS LEADER ISSN 1068-1760
Vol. 35 No.4 • 6-7/2018
DAILY CLINICAL LAB NEWS
®
I
N
T
E
Test Reports Antibiotic Resistance in 2 Hours
R
N
A
T
I
O
Assay Detects Hepatitis B In Multiple Specimens
esistant bacteria are spreading worldwide, which makes fast antibiotic susceptibility testing and determination of the minimal inhibitory concentration (MIC) urgently necessary to select appropriate antibiotic therapy in time.
R
epatitis B virus (HBV) infection has led to more than 686,000 deaths worldwide per year. Approximately two billion individuals worldwide are infected with HBV and are at risk of developing cirrhosis and hepatocellular carcinoma, which ranks fifth
H
Cont’d on page 6
Image: Courtesy of The Children’s Lyme Disease Network
Chip-Based Blood Test Could Make Bone Biopsies Unnecessary
test protocol based on liquid chromatography-mass spectrometry (LC-MS) analysis accurately detects levels of illegal drugs in a single fingerprint from drug users, while eliminating those who had only passive contact with a drug user. In an earlier study, investigators at the University of Surrey (UK; www.surrey.ac.uk) described a test that used a fingerprint to detect
A
See article on page 5
S
I
T
LINKXPRESS COM R E A D E R
S E R V I C E
®
Cont’d on page 6
Access Interactive Digital Magazine Instant Online Product Information:
recently-released line of ELISA tests for neonatal screening is based on Dry Blood Spot (DBS) technology and comprises a menu of eight kits. The kits are the newest diagnostic assays being introduced by Calbiotech (Spring
A
Cont’d on page 5
Cervical Fluid Test Developed For Gynecological Cancers
Identify LinkXpress codes of 1 interest as you read magazine ®
on LinkXpress.com 2 Click to reach reader service portal
3
INSIDE
ELISA-Based Neonatal Screening Line Offers Menu of Eight Kits
P O R T A L
Renew /Start your Free Subscription
Mark code(s) of interest on LinkXpress ® inquiry matrix
If your subscription is not renewed every 12 months your Free Subscription may be automatically discontinued
uberculosis, caused by infection with Mycobacterium tuberculosis (TB), is the world’s leading cause of death brought on by a single pathogen. More than 10 million new cases of TB are diagnosed each year, and almost two million people die from the disease. Those living with someone with active TB are at highest risk for developing the disease, yet
T
Fingerprint Test Detects Heroin and Cocaine Users
T
I
L
Cont’d on page 7
he days of subjecting patients to painful bone biopsies, in order to guide treatment for multiple myeloma and other cancers such as leukemia, may be numbered. A low-cost reliable blood test, that uses a small plastic chip about the size of a credit card, can now deliver the same diagnostic information, but using a simple blood draw instead.
V
A
Blood Test Predicts Onset of TB in Advance
in terms of malignant cancer mortality. A novel HBV assay that offers advantages over currently used methods because it has the capability to detect closed circular DNA (cccDNA) in serum, single cells, and preserved tissue samples. This
Cont’d on page 4
N
ogether, endometrial and ovarian cancers account for about 25,000 deaths each year and are the third leading cause of cancer-related mortality in women in the USA. Most of these deaths are caused by high-grade tumor subtypes, which tend to metasta-
T
size before the onset of symptoms. Cervical fluid samples gathered during routine Papanicolaou (Pap) tests are the basis of a new screening test for endometrial and ovarian cancers. The new screening test called PapSEEK detects mutations in DNA that have been Cont’d on page 4
Clinical News . . . . . 4-60 IFCC Annual Report . 29 IFCC News . . . . . . . . . 61 Product News . . . . . 6-60 Industry News . . . . . . .65 Events Calendar . . . . . 66 PUBLISHED IN COOPERATION WITH
International Federation of Clinical Chemistry and Laboratory Medicine
GLOBETECH >>> MEDIA <<<